HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Piperlongumine exerts cytotoxic effects against cancer cells with mutant p53 proteins at least in part by restoring the biological functions of the tumor suppressor.

Abstract
Piperlongumine (PL), a small molecule alkaloid present in black pepper (Piper longum), has been reported to kill tumor cells irrespective of their p53 gene status, however, the mechanisms involved are unknown. Since p53 is a redox-sensitive protein, we hypothesized that the redox imbalance induced by PL may affect the structure and/or function of the mutant p53 protein and promote cell death. We used two human colon cancer cell lines, the HT29 and SW620 which harbor the R273H DNA contact abrogatory mutation in p53. PL treatment induced significant ROS production and protein glutathionylation with a concomitant increase in Nrf-2 expression in both cell lines. Surprisingly, immunoprecipitation with wt-p53 specific antibodies (PAb1620) or direct western blotting showed a progressive generation of wild-type-like p53 protein along with a loss of its mutant counterpart in PL-treated HT29 and SW620 cells. Moreover, the EMSA and DNA-affinity blotting revealed a time-dependent restoration of DNA-binding for the mutant p53, which was accompanied by the induction of p53 target genes, MDM2 and Bax. PL, while cytotoxic by itself, also increased the cell killing by many anticancer drugs. In nude mice bearing the HT29 tumors, PL alone (7.5 mg/kg daily) produced a 40% decrease in tumor volume, which was accompanied by diminished intratumoral mutant p53 protein levels. The antitumor efficacy of BCNU or doxorubicin in HT29 xenografts was highly potentiated by PL, followed by expression of apoptotic proteins. These clinically-relevant findings suggest that PL-induced oxidative milieu facilitates a weak functional restoration of mutant p53 through protein glutathionylation and contributes to the increased drug sensitivity.
AuthorsDebasish Basak, Surendra R Punganuru, Kalkunte S Srivenugopal
JournalInternational journal of oncology (Int J Oncol) Vol. 48 Issue 4 Pg. 1426-36 (Apr 2016) ISSN: 1791-2423 [Electronic] Greece
PMID26848023 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA-Binding Proteins
  • Dioxolanes
  • Mutant Proteins
  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • Doxorubicin
  • Glutathione
  • piperlongumine
  • Carmustine
Topics
  • Animals
  • Carmustine (administration & dosage)
  • Colonic Neoplasms (drug therapy, genetics, pathology)
  • DNA-Binding Proteins (genetics)
  • Dioxolanes (administration & dosage)
  • Doxorubicin (administration & dosage)
  • Drug Resistance, Neoplasm (genetics)
  • Glutathione (metabolism)
  • HT29 Cells
  • Humans
  • Mice
  • Mutant Proteins (biosynthesis, genetics)
  • Tumor Suppressor Protein p53 (biosynthesis, genetics)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: